tolbutamide has been researched along with gallopamil in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Matthews, EK; Sakamoto, Y | 1 |
| Arkhammar, P; Berggren, PO; Nilsson, T; Welsh, M; Welsh, N | 1 |
| Henquin, JC | 1 |
| Hellman, B; Saha, S | 1 |
5 other study(ies) available for tolbutamide and gallopamil
| Article | Year |
|---|---|
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Electrical characteristics of pancreatic islet cells.
Topics: Action Potentials; Animals; Calcium; Electric Stimulation; Gallopamil; Glucose; In Vitro Techniques; Islets of Langerhans; Membrane Potentials; Mice; Microelectrodes; Potassium; Tolbutamide | 1975 |
Effects of protein kinase C activation on the regulation of the stimulus-secretion coupling in pancreatic beta-cells.
Topics: Animals; Calcium; Carbachol; Cytoplasm; Dimethyl Sulfoxide; Diterpenes; Enzyme Activation; Gallopamil; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Membrane Potentials; Mice; Mice, Obese; Phosphoproteins; Potassium; Protein Kinase C; Terpenes; Tetradecanoylphorbol Acetate; Tolbutamide | 1989 |
Specificity of divalent cation requirement for insulin release. Effects of strontium.
Topics: Animals; Calcium; Cations, Divalent; Cobalt; Egtazic Acid; Gallopamil; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Potassium; Rats; Strontium; Tolbutamide | 1980 |
Alpha 2-adrenergic stimulation counteracts glucose-induced rise of sodium in pancreatic islets exposed to ouabain.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Bucladesine; Calcium Channel Blockers; Clonidine; Diltiazem; Dose-Response Relationship, Drug; Gallopamil; Glucose; In Vitro Techniques; Islets of Langerhans; Kinetics; Mice; Mice, Obese; Sodium; Tolbutamide; Yohimbine | 1995 |